John G. Houston - 23 Feb 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
President and CEO, Director
Signature
/s/ Matthew Batters as attorney-in-fact for John Houston
Issuer symbol
ARVN
Transactions as of
23 Feb 2022
Net transactions value
-$385,175
Form type
4
Filing time
04 Mar 2022, 20:00:26 UTC
Previous filing
03 Nov 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Options Exercise +17,511 +2.1% 849,844 04 Mar 2022 Direct F1
transaction ARVN Common Stock Sale $385,175 -6,024 -0.71% $63.94 843,820 04 Mar 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Stock Option (right to buy) Award $0 +200,500 $0.000000 200,500 23 Feb 2022 Common Stock 200,500 $64.19 Direct F4
transaction ARVN Restricted Stock Units Options Exercise $0 -17,511 -50% $0.000000 17,510 04 Mar 2022 Common Stock 17,511 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2 This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3 The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $63.94.
F4 This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.
F5 On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.